A 47-year-old diabetic man presents with well-demarcated, finely scaled red-brown patches in the inguinal folds and inframammary areas for several months. KOH preparation is negative for hyphae and yeasts. Wood's lamp examination reveals a striking coral-red fluorescence, confirming the diagnosis of erythrasma caused by *Corynebacterium minutissimum*. The structure marked **B** in the diagram represents the most appropriate first-line management for localized disease. Which of the following best describes the rationale for choosing option **B** over the alternatives shown?
A. Topical and oral macrolides (erythromycin/clindamycin) target the gram-positive bacillus directly; antifungals are ineffective against Corynebacterium
B. Topical mupirocin alone is more effective than macrolides and should be used as monotherapy for all cases
C. Antifungal agents like fluconazole and griseofulvin are superior for coral-red fluorescent lesions caused by fungal porphyrins
D. Surgical excision is the gold standard for erythrasma in diabetic patients with intertriginous involvement
Explanation
Why option 0 is right
Erythrasma is caused by the lipophilic gram-positive bacillus Corynebacterium minutissimum, not a fungus. The coral-red fluorescence on Wood's lamp is due to porphyrin (coproporphyrin III) produced by the organism. Topical erythromycin (2%) or clindamycin (1%) applied twice daily for 2–4 weeks is the standard first-line treatment for localized disease. Oral erythromycin 250 mg QID for 5–14 days or clarithromycin 1 g STAT is reserved for extensive or recurrent disease. These macrolide antibiotics directly target the gram-positive bacillus, making them the rational choice (Habif Clinical Dermatology 7e; Bolognia Dermatology 5e).
Why each distractor is wrong
Option 1: Fluconazole and griseofulvin are antifungal agents designed to treat dermatophytes and yeasts. Since erythrasma is a bacterial infection, not a fungal one, these agents are ineffective and represent a common clinical error that delays appropriate treatment.
Option 2: Surgical excision has no role in the management of erythrasma. It is a treatable bacterial infection responsive to topical and systemic antibiotics; surgery is reserved for conditions with structural abnormalities or malignancy, neither of which applies here.
Option 3: While mupirocin and fusidic acid are acceptable alternatives for localized erythrasma, macrolides (erythromycin and clindamycin) remain the gold-standard first-line agents with the strongest evidence base and are preferred over monotherapy with mupirocin alone.
High-YieldNEET PG
Coral-red Wood's lamp fluorescence = erythrasma = Corynebacterium minutissimum = treat with macrolide antibiotics, NOT antifungals.
